Literature DB >> 29578310

Insights into Islet Differentiation and Maturation through Proteomic Characterization of a Human iPSC-Derived Pancreatic Endocrine Model.

Corinne Haller1, Prasad Chaskar1, Julie Piccand1, Ornella Cominetti2, Charlotte Macron2, Loïc Dayon2, Marine R-C Kraus1.   

Abstract

PURPOSE: Great progresses have been made for generating in vitro pluripotent stem cell pancreatic β-like cells. However, the maturation stage of the cells still requires in vivo maturation to recreate the environmental niche. A deeper understanding of the factors promoting maturation of the cells is of great interest for clinical applications. EXPERIMENTAL
DESIGN: Label-free mass spectrometry based proteomic analysis is performed on samples from a longitudinal study of differentiation of human induced pluripotent stem cells toward glucose responsive insulin producing cells.
RESULTS: Proteome patterns correlate with specific transcription factor gene expression levels during in vitro differentiation, showing the relevance of the technology for identification of pancreatic-specific markers. The analysis of proteomes of the implanted cells in a longitudinal study shows that the neovascularization process linked to the extracellular matrix environment is time-dependent and conditions the proper maturation of the cells in β-like cells secreting insulin in response to glucose. CONCLUSIONS AND CLINICAL RELEVANCE: Proteomic profiling is valuable to qualify and better understand in vivo maturation of progenitor cells toward β-cells. This is critical for future clinical trials where in vivo maturation still needs to be improved for robustness and effectiveness of cell therapy. Novel biomarkers for predicting the efficiency of maturation represents noninvasive monitoring tools for following efficiency of the implant.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  diabetes mellitus; differentiation; mass spectrometry; maturation; pluripotent; spectral counting; stem cells

Mesh:

Substances:

Year:  2018        PMID: 29578310     DOI: 10.1002/prca.201600173

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  2 in total

1.  Dynamic proteome profiling of human pluripotent stem cell-derived pancreatic progenitors.

Authors:  Larry Sai Weng Loo; Heidrun Vethe; Andreas Alvin Purnomo Soetedjo; Joao A Paulo; Joanita Jasmen; Nicholas Jackson; Yngvild Bjørlykke; Ivan A Valdez; Marc Vaudel; Harald Barsnes; Steven P Gygi; Helge Raeder; Adrian Kee Keong Teo; Rohit N Kulkarni
Journal:  Stem Cells       Date:  2020-01-22       Impact factor: 6.277

2.  Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice.

Authors:  Corinne Haller; Julie Piccand; Filippo De Franceschi; Yuki Ohi; Anindita Bhoumik; Christophe Boss; Umberto De Marchi; Guillaume Jacot; Sylviane Metairon; Patrick Descombes; Andreas Wiederkehr; Alessio Palini; Nicolas Bouche; Pascal Steiner; Olivia G Kelly; Marine R-C Kraus
Journal:  Stem Cell Reports       Date:  2019-03-07       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.